title: [Biological follow-up of patients with HIV treated with anti-PD-1 or anti-PD-L1 for non-small cell bronchial carcinoma: A task group proposal].
authors.affiliation: Inserm U 1135, département d'immunologie, groupe hospitalier Pitié-Salpêtrière, CIMI, UMPC université Paris VI, Sorbonne universités, 83, boulevard de l'Hôpital, 75013 Paris, France. Electronic address: amelie.guihot@aphp.fr.
authors.forename: A
authors.initials: A
authors.lastname: Guihot
authors.affiliation: Service de pneumologie, hôpital Tenon, GRC 04 Theranoscan, AP-HP, UPMC université Paris VI, Sorbonne universités, 75970 Paris, France.
authors.forename: J
authors.initials: J
authors.lastname: Cadranel
authors.affiliation: Service de médecine interne - immunologie clinique, hôpital du Kremlin-Bicêtre, 94270 Kremlin-Bicêtre, France.
authors.forename: O
authors.initials: O
authors.lastname: Lambotte
authors.affiliation: Service de pneumologie, hôpital Tenon, GRC 04 Theranoscan, AP-HP, UPMC université Paris VI, Sorbonne universités, 75970 Paris, France.
authors.forename: A
authors.initials: A
authors.lastname: Lavolé
authors.affiliation: Inserm U 1135, département d'immunologie, groupe hospitalier Pitié-Salpêtrière, CIMI, UMPC université Paris VI, Sorbonne universités, 83, boulevard de l'Hôpital, 75013 Paris, France.
authors.forename: B
authors.initials: B
authors.lastname: Autran
authors.affiliation: Inserm U 1136, service de cancérologie, groupe hospitalier Pitié-Salpêtrière, UPMC université Paris VI, Sorbonne universités, 75013 Paris, France.
authors.forename: J-P
authors.initials: JP
authors.lastname: Spano
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D015497:HIV-1; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D008991:Monitoring, Physiologic; D061026:Programmed Cell Death 1 Receptor / Q000037:antagonists & inhibitors / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; C105992:PDCD1 protein, human; D061026:Programmed Cell Death 1 Receptor; C000594389:atezolizumab